MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CELUW made $26,550K in revenue. -$91,800K in net income. Net profit margin of -345.76%.

Income Overview

Revenue
$26,550K
Net Income
-$91,800K
Net Profit Margin
-345.76%
EPS
-$3.59
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • License Royalty And Other
    • Service
Revenue Breakdown
    • Degenerative Disease
    • Biobanking
    • Cell Therapy

Income Statement
2025-12-31
Total revenues
26,550
Change in fair value of contingent consideration liability
0
Research and development
15,025
Selling, general and administrative
51,266
Amortization of acquired intangible assets
1,493
Cost of revenues
20,074
Total operating expenses
87,858
Loss from operations
-61,308
Interest income
262
Interest expense
6,754
Change in fair value of warrant liabilities
3,318
Change in fair value of derivative liability
65
Change in fair value of debt
1,809
Loss on debt extinguishment
-6,356
Amortization of licensing obligation premium
1,911
Loss on issuance of convertible notes with warrants
-2,335
Impairment of preferred stock investment
2,890
Compliance fees and other expense, net
-9,181
Total other expense
-30,405
Loss before income taxes
-91,713
Income tax expense (benefit)
3
Net loss
-91,716
Deemed dividend relating to inducement of dragasac warrants
64
Paid-in kind preferred stock dividend
20
Net loss attributable to common shareholders
-91,800
Basic EPS
-3.59
Diluted EPS
-3.59
Basic Average Shares
25,598,586
Diluted Average Shares
25,598,586
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$91,800K Net loss-$91,716K Deemed dividendrelating to inducement of...$64K Paid-in kind preferredstock dividend$20K Loss before incometaxes-$91,713K Income tax expense(benefit)$3K Product$13,175K License Royalty AndOther$7,943K Service$5,432K Loss from operations-$61,308K Total other expense-$30,405K Total revenues$26,550K Amortization of licensingobligation premium$1,911K Interest income$262K Change in fair value ofderivative liability$65K Total operatingexpenses$87,858K Compliance fees and otherexpense, net-$9,181K Interest expense$6,754K Loss on debtextinguishment-$6,356K Change in fair value ofwarrant liabilities$3,318K Impairment of preferredstock investment$2,890K Loss on issuance ofconvertible notes with...-$2,335K Change in fair value ofdebt$1,809K Selling, general andadministrative$51,266K Cost of revenues$20,074K Research and development$15,025K Amortization of acquiredintangible assets$1,493K

Celularity Inc (CELUW)

Celularity Inc (CELUW)